4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001628280-25-027210
Chief Executive Officer returned 20,388 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virnich Daniel Chief Executive Officer | 2025-05-21 | Returned to the company | −20,388 | $2.68 | $54,538 | 1,787,309 | D |
Loading xslF345X05/wk-form4_1747938137.xml…